Related Experiment Video
Updated: Jan 20, 2026
Lytic Cycle of Bacteriophages
Isolation and characterization of novel lytic bacteriophages against (fluoro)quinolone-resistant Campylobacter
Yuran Elías Calancha-Padrón1, Dayana Perez-Condori1, Marcelo Fernando Gutierrez-Valverde1,2
1Área de Bioquímica Molecular, Instituto de Investigaciones Fármaco Bioquímicas, Universidad Mayor de San Andrés, La Paz, Bolivia.
Abstract:
Antimicrobial resistance (AMR) has become a global public health concern, particularly in developing countries where antibiotics are often overused and misused. In Bolivia, the indiscriminate use of antibiotics, including (fluoro-)quinolones, has led to the proliferation of multidrug-resistant (MDR) Campylobacter spp., increasing the risk of resistance gene dissemination to other bacteria, and further deepening the AMR problem. To help mitigate the proliferation of MDR bacteria, bacteriophages can be a valuable complementary treatment to antibiotics. In the present study, we isolated and characterized three novel lytic bacteriophages with activity against (fluoro-)quinolone-resistant Campylobacter isolates and C. jejuni strains. The isolated bacteriophages, BMBo_CjP_006, BMBo_CjP_007, and BMBo_CjP_009, belong to the class Caudoviricetes and possess a linear double-stranded DNA genome. Their genome size ranges from 59 to 77 kb, with a GC-content between 42 to 46%. The 90, 144, and 146 predicted coding sequences (CDSs) of the different bacteriophages did not encode any antibiotic resistance, virulence, or lysogenic-associated genes, confirming their genetic safety and lytic nature. The isolated bacteriophages showed a narrow host range and lytic activity against nine (fluoro-)quinolone-resistant Campylobacter spp., including C. jejuni, with lytic activity varying at MOIs from 0.1 to 100, dependent on bacteriophage and host isolate. In addition, the bacteriophages were stable across a pH range of 4 to 10 and a temperature range of -20 °C to 70 °C. These characteristics make them promising for biotechnological applications due to their lytic activity, lack of resistance and virulence genes, and potential utility for product preservation.
Insights
Three novel bacteriophages were isolated to combat multidrug-resistant Campylobacter, offering a safe, complementary treatment to antibiotics. These lytic phages show stability and potential for biotechnological applications in fighting antimicrobial resistance.
Area of Science:
- Microbiology
- Genetics
- Biotechnology
Background:
- Antimicrobial resistance (AMR) is a growing global health crisis, exacerbated by antibiotic overuse in developing nations.
- Multidrug-resistant (MDR) Campylobacter, particularly fluoroquinolone-resistant strains, poses a significant threat due to potential gene dissemination.
- Bacteriophages present a promising alternative or complementary therapy to antibiotics for combating MDR bacteria.
Purpose of the Study:
- To isolate and characterize novel lytic bacteriophages effective against fluoroquinolone-resistant Campylobacter strains.
- To assess the genetic safety and lytic nature of the isolated bacteriophages.
- To evaluate the stability and potential biotechnological applications of these bacteriophages.
Main Methods:
- Isolation and characterization of three novel lytic bacteriophages (BMBo_CjP_006, BMBo_CjP_007, BMBo_CjP_009).
- Genomic analysis to determine genome size, GC-content, and identify coding sequences (CDSs).
- Assessment of lytic activity against resistant Campylobacter isolates, host range, stability (pH, temperature), and absence of specific genes.
Main Results:
- Three bacteriophages belonging to the class Caudoviricetes with linear dsDNA genomes (59-77 kb) were successfully isolated.
- No antibiotic resistance, virulence, or lysogenic genes were detected in the bacteriophages' CDSs, confirming their safety.
- The bacteriophages exhibited lytic activity against nine fluoroquinolone-resistant Campylobacter strains, including C. jejuni, and demonstrated stability across a wide pH and temperature range.
Conclusions:
- The novel lytic bacteriophages are genetically safe and effective against MDR Campylobacter, including C. jejuni.
- Their stability and specific lytic activity make them suitable candidates for therapeutic applications against AMR.
- These bacteriophages hold potential for biotechnological uses, including product preservation, due to their unique characteristics.
Related Concept Videos
Lytic Cycle of Bacteriophages
05:34Detection and Isolation of Campylobacter spp. from Raw Meat
Lysogenic Cycle of Bacteriophages
Detection of Bacteriophages in Environmental Samples
Demonstrating Author: Alex Wassimi
Viruses are a unique group of biological entities that infect both eukaryotic and prokaryotic organisms. They are obligate parasites that have no metabolic capacity, and in order to replicate, rely on host metabolism to produce viral parts that self-assemble inside host cells.
Viruses are ultramicroscopic—too small to be viewed with the light microscope, visible only...
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
09:43Subtyping of Campylobacter jejuni ssp. doylei Isolates Using Mass Spectrometry-based PhyloProteomics (MSPP)
